Also trades as: AVCNF (OTC) · $vol 0M
AVCN.TO TSX
Avicanna Inc.
1W: -4.8%
1M: -16.7%
3M: -16.7%
YTD: -44.4%
1Y: -63.6%
3Y: -71.4%
5Y: -90.7%
C$0.10 ($0.07)
+0.00 (+0.00%)
Weekly Expected Move ±13.4%
C$0
C$0
C$0
C$0
C$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
#28
of 112
Drug Manufacturers - Specialty & Generic
Technical Signal Map
3 Bullish
1 Neutral
9 Bearish
AVCN.TO
$10M
Avicanna Inc.
BEARISH
-75
GUD.TO
$1.0B
Knight Therapeutics Inc.
BULLISH
+91
XLY.TO
$340M
Auxly Cannabis Group Inc.
BULLISH
+56
21P.F
$220M
Aurora Cannabis Inc. R
BULLISH
+49
ACB
$340M
Aurora Cannabis Inc.
NEUTRAL
0
BHC
$3.0B
Bausch Health Companies Inc.
BEARISH
-33
CRON
$1.7B
Cronos Group Inc.
BEARISH
-68
CRDL
$260M
Cardiol Therapeutics Inc.
BEARISH
-87
APTX.TO
$7.1B
Apotex Health Corp.
BEARISH
-91
TLRY
$570M
Tilray Brands, Inc.
BEARISH
-100
CGC
$370M
Canopy Growth Corporation
BEARISH
-100
CPH.TO
$350M
Cipher Pharmaceuticals Inc.
BEARISH
-100
TSNDF
$240M
TerrAscend Corp.
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| AVCN.TO Avicanna Inc. | $10M | -3.1 | -109.4 | -64.6 | -18.1 | -0.2 | 3 | BEARISH | -63.6 |
| GUD.TO Knight Therapeutics Inc. | $1.0B | 70.2 | 1.9 | 2.5 | -2.3 | 42.3 | 7 | BULLISH | 64.5 |
| XLY.TO Auxly Cannabis Group Inc. | $340M | 10.3 | 20.2 | 3.9 | 16.8 | 18.8 | 8 | BULLISH | 2025.0 |
| 21P.F Aurora Cannabis Inc. R | $220M | — | — | — | — | — | — | BULLISH | — |
| ACB Aurora Cannabis Inc. | $340M | -2.9 | -13.9 | -0.4 | -149.7 | -9.4 | 5 | NEUTRAL | -31.6 |
| BHC Bausch Health Companies Inc. | $3.0B | -2.0 | 86.8 | 12.2 | 9.0 | 10.5 | 5 | BEARISH | -12.2 |
| CRON Cronos Group Inc. | $1.7B | 17.2 | 6.5 | 5.3 | 45.4 | 86.4 | 6 | BEARISH | 21.4 |
| CRDL Cardiol Therapeutics Inc. | $260M | -5.9 | -204.6 | 1592.3 | — | — | 4 | BEARISH | 31.8 |
| APTX.TO Apotex Health Corp. | $7.1B | — | — | — | — | — | — | BEARISH | — |
| TLRY Tilray Brands, Inc. | $570M | -2.7 | -8.1 | -2.7 | -17.6 | 1.2 | 3 | BEARISH | -78.2 |
| CGC Canopy Growth Corporation | $370M | -1.9 | -53.8 | -16.5 | -220.5 | 27.6 | 2 | BEARISH | -36.6 |
| CPH.TO Cipher Pharmaceuticals Inc. | $350M | 8.4 | 23.5 | 24.9 | 33.3 | 3.6 | 6 | BEARISH | -10.6 |
| TSNDF TerrAscend Corp. | $240M | -4.1 | -22.6 | -28.1 | -13.6 | — | 3 | BEARISH | — |
| AVCN.TO Avicanna Inc. | $10M | -3.1 | -109.4 | -64.6 | -18.1 | -0.2 | 3 | BEARISH | -63.6 |
| GUD.TO Knight Therapeutics Inc. | $1.0B | 70.2 | 1.9 | 2.5 | -2.3 | 42.3 | 7 | BULLISH | 64.5 |
| XLY.TO Auxly Cannabis Group Inc. | $340M | 10.3 | 20.2 | 3.9 | 16.8 | 18.8 | 8 | BULLISH | 2025.0 |
| 21P.F Aurora Cannabis Inc. R | $220M | — | — | — | — | — | — | BULLISH | — |
| ACB Aurora Cannabis Inc. | $340M | -2.9 | -13.9 | -0.4 | -149.7 | -9.4 | 5 | NEUTRAL | -31.6 |
| BHC Bausch Health Companies Inc. | $3.0B | -2.0 | 86.8 | 12.2 | 9.0 | 10.5 | 5 | BEARISH | -12.2 |
| CRON Cronos Group Inc. | $1.7B | 17.2 | 6.5 | 5.3 | 45.4 | 86.4 | 6 | BEARISH | 21.4 |
| CRDL Cardiol Therapeutics Inc. | $260M | -5.9 | -204.6 | 1592.3 | — | — | 4 | BEARISH | 31.8 |
| APTX.TO Apotex Health Corp. | $7.1B | — | — | — | — | — | — | BEARISH | — |
| TLRY Tilray Brands, Inc. | $570M | -2.7 | -8.1 | -2.7 | -17.6 | 1.2 | 3 | BEARISH | -78.2 |
| CGC Canopy Growth Corporation | $370M | -1.9 | -53.8 | -16.5 | -220.5 | 27.6 | 2 | BEARISH | -36.6 |
| CPH.TO Cipher Pharmaceuticals Inc. | $350M | 8.4 | 23.5 | 24.9 | 33.3 | 3.6 | 6 | BEARISH | -10.6 |
| TSNDF TerrAscend Corp. | $240M | -4.1 | -22.6 | -28.1 | -13.6 | — | 3 | BEARISH | — |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
AVCN.TO vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F